SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-12-033926
Filing Date
2012-05-07
Accepted
2012-05-07 17:27:28
Documents
4
Effectiveness Date
2012-05-07

Document Format Files

Seq Description Document Type Size
1 DEFA14A a12-11462_1defa14a.htm DEFA14A 66992
2 GRAPHIC g114621bci001.gif GRAPHIC 19954
3 GRAPHIC g114621bei001.gif GRAPHIC 67332
4 GRAPHIC g114621bgi001.gif GRAPHIC 60915
  Complete submission text file 0001104659-12-033926.txt   272698
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-30319 | Film No.: 12818864
SIC: 2834 Pharmaceutical Preparations